Assist. Prof. Dr. Areen Alshweiat, The Hashemite University, Jordan
Assist. Prof. Dr. Areen Alshweiat is a dedicated pharmaceutical scientist at The Hashemite University, Jordan 🇯🇴. She earned her PhD from the University of Szeged, Hungary, specializing in the development of loratadine nanosystems for intranasal delivery using a Quality by Design approach 🎓. Dr. Alshweiat’s expertise spans nanoparticle formulation, smart crystals, electrospinning nanofibers, and nose-to-brain drug delivery 💊🧬. She has authored numerous publications in top journals, focusing on innovative drug delivery systems and bioavailability enhancement. Currently, she serves as the Head of the Department of Pharmaceutics and Pharmaceutical Technology and contributes to regulatory committees at the Jordan Food and Drug Administration 📚🔬.
Publication Profile
Google scholar
Academic Qualifications
Assist. Prof. Dr. Areen Alshweiat holds a distinguished academic background in pharmaceutical sciences. She completed her PhD at the Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Hungary 🇭🇺, where she focused on the “Development and Characterization of Loratadine Nanosystems for Intranasal Delivery Using Quality by Design Approach” 💊. Prior to this, she obtained her Master’s degree in Pharmaceutical Technology from Jordan University of Science and Technology (JUST), with a thesis on the “Preparation and Evaluation of Tacrolimus Solid Dispersion Systems” 🧬. She also holds a Bachelor’s degree in Pharmacy from JUST, graduating in 2009 🎓.
Assist. Prof. Dr. Areen Alshweiat has an extensive background in pharmaceutical sciences, having worked across various esteemed institutions 🌍. She contributed to the Interdisciplinary Centre of Excellence in Hungary, focusing on the development of novel drug-carrier systems (2018-2020) 💊. She also engaged in a project at the University of Edinburgh, Scotland, exploring nanofibers for drug delivery in 2019 🧪. At The Hashemite University, Jordan, she served as a full-time lecturer (2015-2016) and currently holds the role of Assistant Professor and Head of the Department of Pharmaceutics and Pharmaceutical Technology (2020-Present) 🏛️. Additionally, she is a member of the Post Approval Changes and Generic Drugs Registration Committees at the Jordan Food and Drug Administration (2024-Present) 🏥.
Research Interests
Assist. Prof. Dr. Areen Alshweiat’s research focuses on advanced pharmaceutics and pharmaceutical technology 💊. Her expertise spans formulation development, including innovative drug delivery systems like nanoparticles and SmartCrystals 🌟. She has a keen interest in electrospinning nanofibers for enhanced drug delivery applications 🧪. Dr. Alshweiat is particularly dedicated to exploring targeted drug delivery methods, emphasizing intranasal and nose-to-brain delivery systems for improved therapeutic outcomes 🧠. Her work aims to optimize the effectiveness and precision of pharmaceutical formulations, addressing complex drug delivery challenges with cutting-edge techniques 🚀.
Publication Top Notes
- Intranasal nanoparticulate systems as alternative route of drug delivery 🧠📄 – A Alshweiat, R Ambrus, II Csóka, Current Medicinal Chemistry, cited by 81 (2019)
- Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine 🌿💊 – A Alshweiat et al., International Journal of Pharmaceutics, cited by 58 (2020)
- Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation 🌊🔬 – A Alshweiat et al., European Journal of Pharmaceutical Sciences, cited by 58 (2018)
- 3D-printed electrospinning setup for the preparation of loratadine nanofibers 🧵🖨️ – R Ambrus, A Alshweiat et al., International Journal of Pharmaceutics, cited by 31 (2019)
- SmartCrystals for efficient dissolution of poorly water-soluble meloxicam 🌟💧 – R Ambrus, A Alshweiat et al., Pharmaceutics, cited by 14 (2022)
- Flavonoid-based nanomedicines to target tumor microenvironment 🌱🧬 – WH Talib, A Alshweiat et al., OpenNano, cited by 12 (2022)
- QbD based control strategy of loratadine nanosuspensions and dry nanoparticles stabilized by Soluplus® 🛠️📊 – A Alshweiat et al., Farmacia, cited by 10 (2019)
- In vivo tests of a novel wound dressing based on agar aerogel 🩹🧫 – T Athamneh, A Alshweiat et al., International Journal of Biological Macromolecules, cited by 8 (2023)
- Antibiofilm and antimicrobial activity of chitosan-polyacrylic acid nanoparticles 🦠🔬 – A Alshweiat et al., Saudi Pharmaceutical Journal, cited by 6 (2024)
- Recent insights into nanoformulation delivery systems of flavonoids against glioblastoma 🧠🩸 – A Alshweiat et al., Journal of Drug Delivery Science and Technology, cited by 3 (2023)